Forgot your username?
Forgot your password?
Create an account
How To Use The FDA Calendar To Invest
Key Tips On Using The FDA Calendar
FDA News and Approvals
User Submitted Articles
Contribute an Article
News and Analysis
Cellceutix Selects Docetaxel for Combination Arm in Planned Phase 2 Trial for Ovarian Cancer
Cellceutix Corporation (OTC: CTIX), reports, based upon ongoing laboratory studies, the Company intends to use docetaxel for the